FDA/CDC

Portable hematology analyzer gets FDA nod


 

The Food and Drug Administration has granted 510(k) clearance for PixCell Medical’s HemoScreen, a portable hematology analyzer is used to perform a complete blood count at the point of care.

FDA icon

HemoScreen requires a single drop of blood and uses disposable cartridges that provide automatic sample preparation.

HemoScreen can analyze 20 standard complete blood count parameters and produces results within 5 minutes.

Study results suggested that HemoScreen provides results comparable to those of another hematology analyzer, Sysmex XE-2100 (J Clin Pathol. 2016 Aug;69[8]:720-5).

“The HemoScreen delivers lab accurate results,” Avishay Bransky, PhD, CEO of PixCell, said in a statement.

HemoScreen “would be especially useful” in physicians’ offices, emergency rooms, intensive care units, oncology clinics, and remote locations, he added.

HemoScreen makes use of a technology called viscoelastic focusing, which employs microfluidics and machine vision algorithms to analyze cells.

Recommended Reading

Prehospital plasma outperforms standard care
MDedge Hematology and Oncology
Restrictive transfusions do not increase long-term CV surgery risk
MDedge Hematology and Oncology
Transfusion Medicine
MDedge Hematology and Oncology
FDA approves DNA-based blood type test
MDedge Hematology and Oncology
Need blood STAT? Call for a drone
MDedge Hematology and Oncology
Have apheresis units, will travel
MDedge Hematology and Oncology
Protocol violations, missed transfusions among blood delivery errors
MDedge Hematology and Oncology
OMS721 gains orphan designation for HSCT-associated thrombotic microangiopathy
MDedge Hematology and Oncology
Rapid bacterial testing of platelets saves money, reduces waste
MDedge Hematology and Oncology
Antigen profiling may help prevent transfusion complications
MDedge Hematology and Oncology